Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 2251-2300 of 6028 result(s).
CYDY CytoDyn Inc
10/14/2021 7:53:59 AM
It looks more like he played those (16)
CYDY CytoDyn Inc
10/14/2021 7:33:02 AM
I was expecting leronlimab to be we (5)
CYDY CytoDyn Inc
10/14/2021 1:08:32 AM
A bit of shortsightedness from the (28)
CYDY CytoDyn Inc
10/13/2021 10:07:10 PM
Yes, we are a group of 200 retail i (17)
CYDY CytoDyn Inc
10/13/2021 7:29:52 PM
On Reddit ThoughtfulInvesting is st (8)
CYDY CytoDyn Inc
10/13/2021 6:36:36 PM
I hope he does move on and wish him (7)
CYDY CytoDyn Inc
10/13/2021 6:25:42 PM
My, my they are getting a little up (14)
CYDY CytoDyn Inc
10/13/2021 6:03:08 PM
That was $2.5 million well spent by (15)
CYDY CytoDyn Inc
10/13/2021 5:40:53 PM
Just think of those poor saps that (26)
CYDY CytoDyn Inc
10/13/2021 3:20:47 PM
implied covenant of good faith and (1)
CYDY CytoDyn Inc
10/12/2021 8:11:10 PM
Of course not. Amarex seems to have (9)
CYDY CytoDyn Inc
10/12/2021 6:35:34 PM
The phase 3 study hit its primary e (8)
CYDY CytoDyn Inc
10/11/2021 6:46:15 PM
He misspoke and said data rather th (7)
CYDY CytoDyn Inc
10/08/2021 5:51:03 PM
No mention of Oncobreast3Dx since t (2)
CYDY CytoDyn Inc
10/07/2021 11:40:27 AM
Ohm, about PD-L1 inhibitors, doesnâ (12)
CYDY CytoDyn Inc
10/07/2021 10:02:26 AM
They're most likely going to run it (8)
CYDY CytoDyn Inc
10/07/2021 9:57:30 AM
Then the judge will know that the s (3)
CYDY CytoDyn Inc
10/07/2021 9:53:03 AM
I wonder what that Qdoba twunt thin (2)
CYDY CytoDyn Inc
10/07/2021 9:47:51 AM
Across the broad array of cancers t (13)
CYDY CytoDyn Inc
10/07/2021 9:42:24 AM
So there should be little complaint (4)
CYDY CytoDyn Inc
10/07/2021 8:30:12 AM
That's based on the $25 million off (2)
CYDY CytoDyn Inc
10/07/2021 8:06:43 AM
We are working with the FDA for a n (5)
CYDY CytoDyn Inc
10/06/2021 10:02:16 PM
I'm not underestimating. With the f (17)
CYDY CytoDyn Inc
10/06/2021 8:58:55 PM
As a last resort every clinical tri (2)
CYDY CytoDyn Inc
10/06/2021 7:57:13 PM
Does NeuroRX really want to see tha (6)
CYDY CytoDyn Inc
10/06/2021 7:37:38 PM
Isn't it odd the way one's internal (6)
CYDY CytoDyn Inc
10/06/2021 7:10:13 PM
If you want to know how Rosenbaum g (3)
CYDY CytoDyn Inc
10/06/2021 7:06:37 PM
The EDC would be FDA compliant with (4)
CYDY CytoDyn Inc
10/06/2021 6:57:38 PM
Agree. I just don't see how we can (12)
CYDY CytoDyn Inc
10/06/2021 6:40:38 AM
For phase 2 trials and monotherapy (4)
CYDY CytoDyn Inc
10/06/2021 2:44:48 AM
I was under the impression that the (12)
CYDY CytoDyn Inc
10/05/2021 7:59:00 PM
Sure, we'll win the lawsuit - but h (10)
CYDY CytoDyn Inc
10/05/2021 7:15:36 PM
It's a good thing I don't regard an (12)
CYDY CytoDyn Inc
10/05/2021 7:04:11 PM
For longhaulers phase 3 they may be (4)
CYDY CytoDyn Inc
10/05/2021 6:58:16 PM
Amarex initiated arbitration to get (6)
CYDY CytoDyn Inc
10/05/2021 6:45:09 PM
By the way so what if he made 8 mil (3)
CYDY CytoDyn Inc
10/05/2021 6:38:35 PM
Low density lipoprotein is associat (4)
CYDY CytoDyn Inc
10/05/2021 6:21:02 PM
The more folks dig into the list of (6)
CYDY CytoDyn Inc
10/05/2021 5:26:39 PM
There are wrap up provisions in the (4)
CYDY CytoDyn Inc
10/05/2021 8:39:43 AM
I specialize in "opposition researc (7)
CYDY CytoDyn Inc
10/05/2021 8:05:06 AM
Paranoia is not your friend. (2)
CYDY CytoDyn Inc
10/04/2021 9:54:51 PM
Was very funny how many times the g (8)
CYDY CytoDyn Inc
10/04/2021 9:36:55 PM
From the last 13d zoom call. They s (20)
CYDY CytoDyn Inc
10/04/2021 8:43:30 PM
A chiropractor freaking out because (6)
CYDY CytoDyn Inc
10/04/2021 11:49:21 AM
Come on, ohm...that's too easy to s (16)
CYDY CytoDyn Inc
10/04/2021 11:44:06 AM
I still believe that the salary of (9)
CYDY CytoDyn Inc
10/04/2021 11:24:03 AM
Just think if the 13d had control b (4)
CYDY CytoDyn Inc
10/04/2021 11:21:59 AM
What needs to be elucidated? Leronl (2)
CYDY CytoDyn Inc
10/04/2021 11:16:28 AM
Straight up lying. The presentation (5)
CYDY CytoDyn Inc
10/04/2021 11:07:27 AM
I took at look at part of the idiot (27)
Go to page:
  • << First
  • < Previous
  • 45
  • 46
  • Next >

Recent Articles

  • Transforming $100 into Wealth with Strategy Over Five Years
  • The Growth Journey of $100 Investment in Meta Platforms
  • Hewlett Packard Enterprise's Thriving Q3 Performance Review
  • Soapy Joe's Car Wash Expands Operations with New Acquisition
  • Growth of Myelofibrosis Market Driven by Innovative Therapies
  • Alimentation Couche-Tard Elects New Board Members in Meeting
  • Steerpoint Capital Fuels Transformation at Antelope Valley Mall
  • CAPREIT Expands Portfolio with $297 Million in Acquisitions
  • AGNC Investment Corp. Launches New Public Offering of Shares
  • Senseonics Expands Eversense CGM Commercialization Efforts
  • The Growth Journey of Lowe's Companies Stock Over a Decade
  • 17 Education & Technology Group Inc. Reports Q2 Financials
  • Descartes Systems Group Reports Record Revenue Growth for Q2 FY26
  • GitLab Experiences Stock Drop Following Recent Earnings Review
  • New Pacific Metals Posts Strong Financial Results for 2025
  • Asana Reports Impressive Q2 Earnings, Boosting Stock Performance
  • How to Maximize Tax Savings When Exiting Your Small Business
  • FoW Partners and Torie Madore Forge Elevated Veterinary Care
  • Natasha Martinez: Trailblazer in Supply Chain Leadership and Innovation
  • American Eagle Reports Strong Q2 Earnings, Stock Rises
  • C3.ai, Inc. Lawsuit: What Investors Need to Know Now
  • Sotera Health Expands Its Reach with Secondary Stock Offering
  • Assessing Popular Inc. Stock: P/E Ratio Analysis for Investors
  • BNY Pricing Public Offering of Preferred Stock Shares
  • ChargePoint's Q2 Performance Review and Future Expectations
  • Transformational Revitalization of Antelope Valley Mall Begins
  • James Hardie Unveils Its Commitment to Sustainable Practices
  • GreenPower Motor Company Announces TSX Venture Trading Update
  • ecoATM Welcomes Matt Furlong as New CEO for Growth Phase
  • AGNC Investment Corp. Engages in Major Public Offering Event
  • New Pacific Metals Corp. Reports Strong Financial Performance
  • Attentive Shines in 2025 Forbes Cloud 100 Rankings
  • Univest Securities Facilitates $9 Million Funding for NXTT
  • Altai Resources Secures Shareholder Support for Capital Reduction
  • Bird Construction Acquires Major Marine Infrastructure Firm
  • Descartes Systems Group Offers Strong Q2FY26 Results Insights
  • LifeVantage Strengthens Health Solutions with LoveBiome Deal
  • Sotera Health Launches Significant Secondary Common Stock Offering
  • vTv Therapeutics Navigates the Path to Investor Conferences
  • Investing Insights: AbbVie Stock Growth Over Five Years
  • C3.ai Dynamics: Earnings Report Insights and Leadership Change
  • SortPak Rx Steals the Spotlight as a Fast-Growing Innovator
  • Discover the Revolutionary TCL NXTPAPER 11 Gen 2 Tablet
  • Neonode Expects Major Financial Gains from Patent Settlement
  • Neonode Surges Ahead with Financial Gains from Settlement
  • Artelo Biosciences Pursues Public Offering to Enhance Growth
  • YT Jia's Recent Stock Purchase Highlights Confidence in FF's Future
  • Avadel Pharmaceuticals Secures Licenses for New Sleep Disorders Treatment
  • WillScot Welcomes New CEO as Leadership Evolves for Growth
  • Americold Realty Trust Announces Consistent Dividend Payments
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site